Relationship of serum total cholesterol and triglyceride with risk of mortality in maintenance hemodialysis patients: a multicenter prospective cohort study

References

• Noh H, Jeon Y, Kim J, et al. Higher serum total cholesterol to high-density lipoprotein cholesterol ratio is associated with increased mortality among incident peritoneal dialysis patients. Nutrients. 2022;14(1):1. doi: 10.3390/nu14010144.
   Web of Science ®Google Scholar
• Saran R, Robinson B, Abbott KC, et al. US renal data system 2016 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2017;69(3 Suppl 1):A7–10. doi: 10.1053/j.ajkd.2016.12.004.
   PubMed Web of Science ®Google Scholar
• Thomas B, Wulf S, Bikbov B, et al. Maintenance dialysis throughout the world in years 1990 and 2010. J Am Soc Nephrol. 2015;26(11):2621–2633. doi: 10.1681/ASN.2014101017.
   PubMed Web of Science ®Google Scholar
• Jung E, Kong SY, Ro YS, et al. Serum cholesterol levels and risk of cardiovascular death: a systematic review and a dose-response meta-analysis of prospective cohort studies. Int J Environ Res Public Health. 2022;19(14):8272. doi: 10.3390/ijerph19148272.
   PubMed Web of Science ®Google Scholar
• Harari G, Green MS, Magid A, et al. Usefulness of non-high-density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men in 22-year follow-up. Am J Cardiol. 2017;119(8):1193–1198. doi: 10.1016/j.amjcard.2017.01.008.
   PubMed Web of Science ®Google Scholar
• Klempfner R, Erez A, Sagit BZ, et al. Elevated triglyceride level is independently associated with increased all-cause mortality in patients with established coronary heart disease: twenty-two-year follow-up of the bezafibrate infarction prevention study and registry. Circ Cardiovasc Qual Outcomes. 2016;9(2):100–108. doi: 10.1161/CIRCOUTCOMES.115.002104.
   PubMed Web of Science ®Google Scholar
• Gu X, Li Y, Chen S, et al. Association of lipids with ischemic and hemorrhagic stroke: a prospective cohort study among 267 500 Chinese. Stroke. 2019;50(12):3376–3384. doi: 10.1161/STROKEAHA.119.026402.
   PubMed Web of Science ®Google Scholar
• Habib AN, Baird BC, Leypoldt JK, et al. The association of lipid levels with mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant. 2006;21(10):2881–2892. doi: 10.1093/ndt/gfl272.
   PubMed Web of Science ®Google Scholar
• Park CH, Kang EW, Park JT, et al. Association of serum lipid levels over time with survival in incident peritoneal dialysis patients. J Clin Lipidol. 2017;11(4):945–954.e3. doi: 10.1016/j.jacl.2017.06.004.
   PubMed Web of Science ®Google Scholar
• Ebert T, Qureshi AR, Lamina C, et al. Time-dependent lipid profile inversely associates with mortality in hemodialysis patients - independent of inflammation/malnutrition. J Intern Med. 2021;290(4):910–921. doi: 10.1111/joim.13291.
   PubMed Web of Science ®Google Scholar
• Nakano T, Hiyamuta H, Yotsueda R, et al. Higher cholesterol level predicts cardiovascular event and inversely associates with mortality in hemodialysis patients: 10-year outcomes of the Q-cohort study. Ther Apher Dial. 2020;24(4):431–438. doi: 10.1111/1744-9987.13455.
   PubMed Web of Science ®Google Scholar
• Moradi H, Abhari P, Streja E, et al. Association of serum lipids with outcomes in hispanic hemodialysis patients of the west versus east coasts of the United States. Am J Nephrol. 2015;41(4–5):284–295. doi: 10.1159/000381991.
   PubMed Web of Science ®Google Scholar
• Lin YC, Lin YC, Chen HH, et al. Different effect of hypercholesterolemia on mortality in hemodialysis patients based on coronary artery disease or myocardial infarction. Lipids Health Dis. 2016;15(1):211. doi: 10.1186/s12944-016-0380-7.
   PubMedGoogle Scholar
• Shoji T, Masakane I, Watanabe Y, et al. Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients. Clin J Am Soc Nephrol. 2011;6(5):1112–1120. doi: 10.2215/CJN.09961110.
   PubMed Web of Science ®Google Scholar
• Zhan X, Yang M, Zhou R, et al. Triglyceride to high-density lipoprotein cholesterol ratio is associated with increased mortality in older patients on peritoneal dialysis. Lipids Health Dis. 2019;18(1):199. doi: 10.1186/s12944-019-1147-8.
   PubMed Web of Science ®Google Scholar
• Liu Y, Coresh J, Eustace JA, et al. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA. 2004;291(4):451–459. doi: 10.1001/jama.291.4.451.
   PubMed Web of Science ®Google Scholar
• Kilpatrick RD, McAllister CJ, Kovesdy CP, et al. Association between serum lipids and survival in hemodialysis patients and impact of race. J Am Soc Nephrol. 2007;18(1):293–303. doi: 10.1681/ASN.2006070795.
   PubMed Web of Science ®Google Scholar
• Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73(4):391–398. doi: 10.1038/sj.ki.5002585.
   PubMed Web of Science ®Google Scholar
• Bross R, Noori N, Kovesdy CP, et al. Dietary assessment of individuals with chronic kidney disease. Semin Dial. 2010;23(4):359–364. doi: 10.1111/j.1525-139X.2010.00743.x.
   PubMed Web of Science ®Google Scholar
• Conway JM, Ingwersen LA, Moshfegh AJ. Accuracy of dietary recall using the USDA five-step multiple-pass method in men: an observational validation study. J Am Diet Assoc. 2004;104(4):595–603. doi: 10.1016/j.jada.2004.01.007.
   PubMedGoogle Scholar
• Conway JM, Ingwersen LA, Vinyard BT, et al. Effectiveness of the US department of agriculture 5-step multiple-pass method in assessing food intake in obese and non-obese women. Am J Clin Nutr. 2003;77(5):1171–1178. doi: 10.1093/ajcn/77.5.1171.
   PubMed Web of Science ®Google Scholar
• Liu S, Wu X, Lopez AD, et al. An integrated national mortality surveillance system for death registration and mortality surveillance, China. Bull World Health Organ. 2016;94(1):46–57. doi: 10.2471/BLT.15.153148.
   PubMed Web of Science ®Google Scholar
• Aristodemou P, Sparrow JM, Kaye S. Evaluating refractive outcomes after cataract surgery. Ophthalmology. 2019;126(1):13–18. doi: 10.1016/j.ophtha.2018.07.009.
   PubMed Web of Science ®Google Scholar
• Lin YC, Lin YC, Peng CC, et al. Effects of cholesterol levels on mortality in patients with long-term peritoneal dialysis based on residual renal function. Nutrients. 2018;10(3):10. doi: 10.3390/nu10030300.
   Web of Science ®Google Scholar
• Iseki K, Yamazato M, Tozawa M, et al. Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int. 2002;61(5):1887–1893. doi: 10.1046/j.1523-1755.2002.00324.x.
   PubMed Web of Science ®Google Scholar
• Chmielewski M, Verduijn M, Drechsler C, et al. Low cholesterol in dialysis patients–causal factor for mortality or an effect of confounding? Nephrol Dial Transplant. 2011;26(10):3325–3331. doi: 10.1093/ndt/gfr008.
   PubMed Web of Science ®Google Scholar
• Xie Q, Shang D, Wang Y, et al. The association between baseline serum lipids and mortality in peritoneal dialysis patients. Blood Purif. 2022;51(2):101–110. doi: 10.1159/000513945.
   PubMed Web of Science ®Google Scholar
• März W, Genser B, Drechsler C, et al. Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis. Clin J Am Soc Nephrol. 2011;6(6):1316–1325. doi: 10.2215/CJN.09121010.
   PubMed Web of Science ®Google Scholar
• Silbernagel G, Fauler G, Genser B, et al. Intestinal cholesterol absorption, treatment with atorvastatin, and cardiovascular risk in hemodialysis patients. J Am Coll Cardiol. 2015;65(21):2291–2298. doi: 10.1016/j.jacc.2015.03.551.
   PubMed Web of Science ®Google Scholar
• Chang TI, Streja E, Soohoo M, et al. Association of serum triglyceride to HDL cholesterol ratio with all-cause and cardiovascular mortality in incident hemodialysis patients. Clin J Am Soc Nephrol. 2017;12(4):591–602. doi: 10.2215/CJN.08730816.
   PubMed Web of Science ®Google Scholar
• Kaysen GA, Ye X, Raimann JG, et al. Lipid levels are inversely associated with infectious and all-cause mortality: international MONDO study results. J Lipid Res. 2018;59(8):1519–1528. doi: 10.1194/jlr.P084277.
   PubMed Web of Science ®Google Scholar
• Postorino M, Marino C, Tripepi G, et al. Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients. Kidney Int. 2011;79(7):765–772. doi: 10.1038/ki.2010.493.
   PubMed Web of Science ®Google Scholar
• Moradi H, Streja E, Vaziri ND. ESRD-induced dyslipidemia-Should management of lipid disorders differ in dialysis patients? Semin Dial. 2018;31(4):398–405. doi: 10.1111/sdi.12706.
   PubMed Web of Science ®Google Scholar
• Weichhart T, Kopecky C, Kubicek M, et al. Serum amyloid A in uremic HDL promotes inflammation. J Am Soc Nephrol. 2012;23(5):934–947. doi: 10.1681/ASN.2011070668.
   PubMed Web of Science ®Google Scholar
• Soohoo M, Moradi H, Obi Y, et al. Serum triglycerides and mortality risk across stages of chronic kidney disease in 2 million U.S. veterans. J Clin Lipidol. 2019;13(5):744–753.e15. doi: 10.1016/j.jacl.2019.08.001.
   PubMed Web of Science ®Google Scholar
• Zhao D, Guallar E, Ouyang P, et al. Endogenous sex hormones and incident cardiovascular disease in post-menopausal women. J Am Coll Cardiol. 2018;71(22):2555–2566. doi: 10.1016/j.jacc.2018.01.083.
   PubMed Web of Science ®Google Scholar
• Song QB, Zhao Y, Liu YQ, et al. Sex difference in the prevalence of metabolic syndrome and cardiovascular-related risk factors in urban adults from 33 communities of China: the CHPSNE study. Diab Vasc Dis Res. 2015;12(3):189–198. doi: 10.1177/1479164114562410.
   PubMed Web of Science ®Google Scholar
• He J, Gu D, Wu X, et al. Major causes of death among men and women in China. N Engl J Med. 2005;353(11):1124–1134. doi: 10.1056/NEJMsa050467.
   PubMed Web of Science ®Google Scholar
• Burchfiel CM, Laws A, Benfante R, et al. Combined ­effects of HDL cholesterol, triglyceride, and total cholesterol concentrations on 18-year risk of atherosclerotic disease. Circulation. 1995;92(6):1430–1436. doi: 10.1161/01.cir.92.6.1430.
   PubMed Web of Science ®Google Scholar
• Bellosta S, Ferri N, Bernini F, et al. Non-lipid-related effects of statins. Ann Med. 2000;32(3):164–176. doi: 10.3109/07853890008998823.
   PubMed Web of Science ®Google Scholar
• Baigent C, Landray M, Warren M. Statin therapy in kidney disease populations: potential benefits beyond lipid lowering and the need for clinical trials. Curr Opin Nephrol Hypertens. 2004;13(6):601–605. doi: 10.1097/00041552-200411000-00004.
   PubMed Web of Science ®Google Scholar
• Chawla V, Greene T, Beck GJ, et al. Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease. Clin J Am Soc Nephrol. 2010;5(9):1582–1587. doi: 10.2215/CJN.01450210.
   PubMed Web of Science ®Google Scholar